12 July 2024 - Geneva, Switzerland - On behalf of Stop TB Partnership's Global Drug Facility (GDF), i+solutions, the GDF-contracted procurement agent, invites all eligible suppliers to submit bids for:
ITB-Iplus/GDF-MED/2024/1, for delamanid 50mg tablets and delamanid 25mg dispersible tablets for the period 1 September 2024 until 31 December 2025.
The purpose of the ITBs is to select a panel of suppliers who will enter into a long-term agreement with i+solutions for delamanid 50mg tablets and delamanid 25mg dispersible tablets.
The ITBs are open to bidders whose products have been deemed eligible for inclusion in the tender in compliance with GDF's Quality Assurance policy and procedures (https://www.stoptb.org/suppliers/quality-assurance). A bid submitted for a product/s for which the bidder has not received regulatory approval status in accordance with the GDF Quality Assurance policy and procedures shall not be considered for the ITB evaluation.
All bids are subject to the Instructions to Bidders and other provisions, specifications and instructions as contained in this dossier.
The ITB comprises of the following:
Annex A. Financial Bid Response Form (Excel file)
Annex B. List and technical specifications of products requested
Annex C. List of priority countries for TB medicines registration
Annex D. i+solutions model Long-Term Agreement (LTA)
Annex E. i+solutions Code of Conduct for suppliers
Annex F. CDP technical tender submission – instructions for use
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines
Annex H. Indicative non-binding estimated quantities
Annex J. GDF packaging artwork development guidelines
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding
Annex L. Declaration of supply restrictions to countries
Bidders are requested to quote unit prices in accordance with the following delivery terms: EXW (Ex-Works), FCA (Free Carrier Alongside) and DAP India.
Failure to adhere to the requirements of the ITB may lead to disqualification of the bidder and/or rejection of the bid.
Deadline for the Request for Clarification on the ITB:
19 July 2024, 17h00 IST (India Standard Time) / 13h30 CET (Central European Time)
Deadline for electronic submission of Technical and Financial Bids:
6 August 2024, 17h00 IST (India Standard Time) / 13h30 CET (Central European Time)
Any bids submitted after the deadline will be rejected and not be considered during the evaluation.
Opening of the Financial Bids, accessible remotely to all Bidders, will take place on
7 August 2024 at 13h30 IST (India Standard Time) / 10h00 CET (Central European Time)
27 Jun 2024 - Geneva, Switzerland: the Global Drug Facility (GDF) and the Global Fund have published a joint Request for Proposal (RFP) for the Quality Control Agent services and invite all eligible service providers to submit their proposals.
The link to the RFP documents is in here: Negotiation Abstracts (oraclecloud.com)
Deadline for the Clarifications and Questions on the RFP: 15 Jul 2024
RFP closing date and time: 07 Aug 2024, 17h00 CET (Central European Time)
Any proposal submitted after the deadline will be rejected and not be considered during the evaluation.